126 related articles for article (PubMed ID: 29503123)
1. High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin.
Yang D; Han Z; Alam MM; Oppenheim JJ
Semin Immunol; 2018 Aug; 38():49-53. PubMed ID: 29503123
[TBL] [Abstract][Full Text] [Related]
2. Harnessing the alarmin HMGN1 for anticancer therapy.
Yang D; Bustin M; Oppenheim JJ
Immunotherapy; 2015; 7(11):1129-31. PubMed ID: 26567750
[No Abstract] [Full Text] [Related]
3. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses.
Yang D; Postnikov YV; Li Y; Tewary P; de la Rosa G; Wei F; Klinman D; Gioannini T; Weiss JP; Furusawa T; Bustin M; Oppenheim JJ
J Exp Med; 2012 Jan; 209(1):157-71. PubMed ID: 22184635
[TBL] [Abstract][Full Text] [Related]
4. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways.
Alam MM; Yang D; Trivett A; Meyer TJ; Oppenheim JJ
Front Immunol; 2018; 9():2982. PubMed ID: 30619338
[TBL] [Abstract][Full Text] [Related]
5. Release mechanism of high mobility group nucleosome binding domain 1 from lipopolysaccharide-stimulated macrophages.
Murakami T; Hu Z; Tamura H; Nagaoka I
Mol Med Rep; 2016 Apr; 13(4):3115-20. PubMed ID: 26935015
[TBL] [Abstract][Full Text] [Related]
6. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant.
Wei F; Yang D; Tewary P; Li Y; Li S; Chen X; Howard OM; Bustin M; Oppenheim JJ
Cancer Res; 2014 Nov; 74(21):5989-98. PubMed ID: 25205103
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells.
Arts RJW; Huang PK; Yang D; Joosten LAB; van der Meer JWM; Oppenheim JJ; Netea MG; Cheng SC
Front Immunol; 2018; 9():526. PubMed ID: 29593748
[TBL] [Abstract][Full Text] [Related]
8. Alarmin-painted exosomes elicit persistent antitumor immunity in large established tumors in mice.
Zuo B; Qi H; Lu Z; Chen L; Sun B; Yang R; Zhang Y; Liu Z; Gao X; You A; Wu L; Jing R; Zhou Q; Yin H
Nat Commun; 2020 Apr; 11(1):1790. PubMed ID: 32286296
[TBL] [Abstract][Full Text] [Related]
9. Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.
Liu Z; Lu Z; Jing R; Zuo B; Gao X; Han G; Qi H; Wu L; Liu Y; Yin H
Theranostics; 2019; 9(14):4006-4018. PubMed ID: 31281528
[TBL] [Abstract][Full Text] [Related]
10. Alarmins and Antitumor Immunity.
Nie Y; Yang D; Oppenheim JJ
Clin Ther; 2016 May; 38(5):1042-53. PubMed ID: 27101817
[TBL] [Abstract][Full Text] [Related]
11. The nucleosome binding protein HMGN1 interacts with PCNA and facilitates its binding to chromatin.
Postnikov YV; Kurahashi T; Zhou M; Bustin M
Mol Cell Biol; 2012 May; 32(10):1844-54. PubMed ID: 22393258
[TBL] [Abstract][Full Text] [Related]
12. Alarmins and immunity.
Yang D; Han Z; Oppenheim JJ
Immunol Rev; 2017 Nov; 280(1):41-56. PubMed ID: 29027222
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with HMGN1 and anti-CD4 depleting antibody reverses T cell exhaustion and exerts robust anti-tumor effects in mice.
Chen CY; Ueha S; Ishiwata Y; Yokochi S; Yang D; Oppenheim JJ; Ogiwara H; Shichino S; Deshimaru S; Shand FHW; Shibayama S; Matsushima K
J Immunother Cancer; 2019 Jan; 7(1):21. PubMed ID: 30696484
[TBL] [Abstract][Full Text] [Related]
14. High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer.
Wei F; Yang F; Jiang X; Yu W; Ren X
Tumour Biol; 2015 Dec; 36(12):9405-10. PubMed ID: 26113410
[TBL] [Abstract][Full Text] [Related]
15. Genomic profiling of HMGN1 reveals an association with chromatin at regulatory regions.
Cuddapah S; Schones DE; Cui K; Roh TY; Barski A; Wei G; Rochman M; Bustin M; Zhao K
Mol Cell Biol; 2011 Feb; 31(4):700-9. PubMed ID: 21173166
[TBL] [Abstract][Full Text] [Related]
16. IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway.
Yu J; Da J; Dong R; Sun Y; Nie Y; Yu F; Zuo L; Zha Y
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):241-250. PubMed ID: 29384065
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal protein HMGN1 modulates histone H3 phosphorylation.
Lim JH; Catez F; Birger Y; West KL; Prymakowska-Bosak M; Postnikov YV; Bustin M
Mol Cell; 2004 Aug; 15(4):573-84. PubMed ID: 15327773
[TBL] [Abstract][Full Text] [Related]
18. The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.
Abuhatzira L; Shamir A; Schones DE; Schäffer AA; Bustin M
J Biol Chem; 2011 Dec; 286(49):42051-42062. PubMed ID: 22009741
[TBL] [Abstract][Full Text] [Related]
19. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells.
Kim JS; Kim WS; Choi HG; Jang B; Lee K; Park JH; Kim HJ; Cho SN; Shin SJ
J Leukoc Biol; 2013 Oct; 94(4):733-49. PubMed ID: 23825389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
